This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Cazzola, M. Search for Related Content PubMed PubMed Citation Articles by Cazzola, M. Social Bookmarking                         What's this?

From large clinical trials to management of COPD in the real world

University of Rome 'Tor Vergata', Department of Internal Medicine, Unit of Respiratory Diseases, Rome, Italy, mario.cazzola{at}uniroma2.it

Large clinical trials in chronic obstructive pulmonary disease (COPD) are analyzed and discussed. Unfortunately, all of them have failed to reach their primary endpoint, which has mainly been the effect on the rate of decline in mean FEV₁ (forced expiratory volume in 1 second). Nonetheless, almost all trials have demonstrated benefits in important outcomes such as exacerbation frequency, symptoms, quality of life and other measures of health status, which are arguably more meaningful to individual patients than FEV ₁ per se.

Key Words: COPD • clinical trials • formoterol salmeterol • tiotropium • budesonide • fluticasone

Therapeutic Advances in Respiratory Disease, Vol. 3, No. 1, 39-46 (2009)
DOI: 10.1177/1753465809102381


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?